You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 9, September 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (54)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Intravitreous Triamcinolone Acetonide as Treatment for Macular Edema From Central Retinal Vein Occlusion

Arch Ophthalmol. 2002;120:1217-1219.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Central retinal vein occlusion (CRVO) is a common retinal vascular disorder that can lead to significant visual disability. Persistent macular edema is one of the major complications associated with CRVO. The Central Vein Occlusion Study1 evaluated the efficacy of macular grid laser photocoagulation in patients with macular edema caused by CRVO. This study did not find a difference in visual acuity between treated and untreated eyes at any stage during the follow-up period. Therefore, there is currently no proven management for macular edema in the setting of CRVO. The purpose of this interventional case report is to describe the clinical course of 2 patients with macular edema secondary to CRVO who underwent intravitreous injection of triamcinolone acetonide.

Report of Cases

Case 1

A 57-year-old man had a 2-month history of decreased visual acuity in his right eye. On initial examination, his best-corrected visual acuity was 20/40 OD and 20/20 OS. Results of anterior segment examination . . . [Full Text of this Article]

Case 2


Comment
Corresponding author and reprints: Michael S. Ip, MD, University of Wisconsin–Madison, Department of Ophthalmology and Visual Sciences, 600 Highland Ave, F4/336, Madison, WI 53792 (e-mail: msip@facstaff.wisc.edu).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Decreased retinal vein diameter after intravitreal triamcinolone for retinal vein occlusions
Jonas and Rensch
Br. J. Ophthalmol. 2007;91:1711-1712.
FULL TEXT  

Effects of triamcinolone acetonide injections with and without preservative
Jonas
Br. J. Ophthalmol. 2007;91:1099-1101.
FULL TEXT  

The management of retinal vein occlusion: is interventional ophthalmology the way forward?
Shahid et al.
Br. J. Ophthalmol. 2006;90:627-639.
ABSTRACT | FULL TEXT  

Effect of Intravitreal Triamcinolone Acetonide on Susceptibility to Experimental Bacterial Endophthalmitis and Subsequent Response to Treatment
Bucher et al.
Arch Ophthalmol 2005;123:649-653.
ABSTRACT | FULL TEXT  

New Therapy for Central Retinal Vein Occlusion: Are Intravitreal Steroids a Possible Answer?
Blumenkranz
Arch Ophthalmol 2005;123:259-261.
FULL TEXT  

Intravitreal Triamcinolone for the Treatment of Macular Edema Associated With Central Retinal Vein Occlusion
Ip et al.
Arch Ophthalmol 2004;122:1131-1136.
ABSTRACT | FULL TEXT  

Intravitreal Triamcinolone for the Management of Macular Edema Due to Nonischemic Central Retinal Vein Occlusion
Bashshur et al.
Arch Ophthalmol 2004;122:1137-1140.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.